Natural products from untapped sources as a potent reserve against antimicrobial resistance crisis

Keywords

Natural products / Untapped sources / Antimicrobial resistance

References

[1] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis[J]. Lancet, 2022, 399(10325): 629-655.

[2] Lewis K. Antibiotics: recover the lost art of drug discovery[J]. Nature, 2012, 485(7399): 439-440.

[3] Shukla R, Peoples AJ, Ludwig KC, et al. An antibiotic from an uncultured bacterium binds to an immutable target[J]. Cell, 2023, 186(19): 4059-4073.

[4] Ling LL, Schneider T, Peoples AJ, et al. A new antibiotic kills pathogens without detectable resistance[J]. Nature, 2015, 517(7535): 455-459.

[5] Gavrish E, Sit CS, Cao S, et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2[J]. Chem Biol, 2014, 21(4): 509-518.

[6] Quigley J, Peoples A, Sarybaeva A, et al. Novel antimicrobials from uncultured bacteria acting against Mycobacterium tuberculosis[J]. mBio, 2020, 11(4): e01516-e01520.

[7] Samy RP, Stiles BG, Franco OL, et al. Animal venoms as antimicrobial agents[J]. Biochem Pharmacol, 2017, 134: 127-138.

[8] Ma J, Huang H, Xie Y, et al. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents[J]. Nat Commun, 2017, 8(1): 391.

[9] Shu WS, Huang LN. Microbial diversity in extreme environments[J]. Nat Rev Microbiol, 2022, 20(4): 219-235.

[10] Alanjary M, Kronmiller B, Adamek M, et al. The antibiotic resistant target seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery[J]. Nucleic Acids Res, 2017, 45: W42-W48.

[11] Stokes JM, Yang K, Swanson K, et al. A deep learning approach to antibiotic discovery[J]. Cell, 2020, 180(4): 688-702.

[12] O’Rourke A, Beyhan S, Choi Y, et al. Mechanism-of-action classification of antibiotics by global transcriptome profiling[J]. Antimicrob Agents Chemother, 2020, 64(3): e01207-e01219.

[13] Johnson EO, LaVerriere E, Office E, et al. Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes[J]. Nature, 2019, 571(7763): 72-78.